Clinical Trials Logo

Clinical Trial Summary

The study's goal is to check and verify basic assumptions of a new selective mutism developmental model from Melfsen and Walitza through standardized and routinely used patient questionnaires. The primary emphasis is the question of a connection between selective mutism and high sensitivity, dissociation, emotional regulation, family structure, social anxiety and self-esteem.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04233905
Study type Observational
Source Psychiatric University Hospital, Zurich
Contact
Status Completed
Phase
Start date August 1, 2017
Completion date July 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00554749 - What Treatment Works for Children With Selective Mutism? N/A
Completed NCT04585048 - The Efficacy of Integrated Behavioral Therapy for Selective Mutism N/A
Completed NCT04291638 - Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism N/A
Completed NCT01002196 - Randomised Controlled Treatment Study of Selective Mutism Phase 2
Completed NCT02009839 - Web-Based CBT Protocol for Treatment of Selective Mutism N/A
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Completed NCT02051192 - Brief Behavioral Treatment for Anxiety in Young Children Phase 1/Phase 2
Completed NCT00458198 - Integrated Behavioral Therapy for Treating Children With Selective Mutism N/A
Completed NCT05378711 - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine Phase 2
Completed NCT03612102 - Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism N/A